SCHEMBL637555

SCHEMBL637555

CCC(CN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27892466 1.00
SCHEMBL5549937 1.00
Ammonia Solution, Strong SCHEMBL9760251 0.97
Hydrochloric Acid SCHEMBL2651955 0.97
Methylamine SCHEMBL27900431 0.82 CA2 (0.64)
Hydroxyamine SCHEMBL4703121 0.82 CA2 (0.64)
SCHEMBL6114 0.82
SCHEMBL902752 0.82
SCHEMBL3996450 0.80 SLC1A2 (0.48)
SCHEMBL15020400 0.80 SLC1A2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250344597-A1 SOLUTION-PROCESSED PEROVSKITE HETEROSTRUCTURES WILLIAM MARSH RICE UNIVERSITY (US) 2025-11-06 US disclosed
US-12281149-B2 Modulators of G-protein coupled receptors CARMOT THERAPEUTICS, INC. (US) 2025-04-22 US disclosed
US-20250115773-A1 TWO-DIMENSIONAL PEROVSKITE TEMPLATES FOR DURABLE AND EFFICIENT PEROVSKITE SOLAR CELLS AND OPTOELECTRONIC DEVICES WILLIAM MARSH RICE UNIVERSITY (US) 2025-04-10 US disclosed
US-20240383960-A1 Modulators of G-Protein Coupled Receptors CARMOT THERAPEUTICS INC. (US) 2024-11-21 US disclosed
CN-117980325-A Modulators of G-protein coupled receptors 卡莫特治疗学股份有限公司 2024-05-03 CN disclosed
EP-4337682-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS Carmot Therapeutics Inc. (US) 2024-03-20 EP disclosed
CN-116848125-A H4 antagonist compounds 赫帕雷斯治疗有限公司 2023-10-03 CN disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
EP-1135476-A1 BIOLOGICAL COMPOSITIONS, COMPONENTS THEREOF AND USES THEREFOR Melbourne Health (AU) 2001-09-26 EP disclosed
WO-2001062958-A1 ASSESSMENT OF THE FUNCTIONAL SIGNIFICANCE OF A NUCLEOTIDE SEQUENCE BY SUBJECTING THE READING FRAME DATA TO DATA PROCESSING NATIONAL CANCER CENTRE OF SINGAPORE PTE LTD. (SG) 2001-08-30 WO disclosed
JP-2001039941-A NEW OPTICALLY ACTIVE 4-AMINO-2-METHYL BUTYRIC ACID DERIVATIVE AND ITS PREPARATION MITSUBISHI RAYON CO LTD 2001-02-13 JP disclosed
WO-2000028009-A1 BIOLOGICAL COMPOSITIONS, COMPONENTS THEREOF AND USES THEREFOR MELBOURNE HEALTH (AU) 2000-05-18 WO disclosed
EP-0506478-B1 Piperidine derivatives LILLY CO ELI (US) 1997-09-03 EP disclosed
US-5250542-A Prevention of side effects induced by narcotics used as analgesics such as constipation, nausea and vomiting; 1-carboxyalkyl-4-methyl-4-(3-oxyphenyl)piperidines such as alvimopan ELI LILLY AND COMPANY (US) 1993-10-05 US disclosed
EP-0506478-A1 Piperidine derivatives ELI LILLY AND COMPANY (US) 1992-09-30 EP disclosed
EP-0407798-A2 Process for the preparation of aqueous polyurethane dispersions. BAYER AG (DE) 1991-01-16 EP disclosed
EP-0051234-B1 A PROCESS FOR THE PRODUCTION OF A 2-AZETIDINONE DERIVATIVE ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1985-03-13 EP disclosed
EP-0051234-A1 A process for the production of a 2-azetidinone derivative ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1982-05-12 EP disclosed